Tailored eradication <i>vs</i> empirical bismuth-containing quadruple therapy for first-line <i>Helicobacter pylori</i> eradication: A comparative, open trial

Abstract

DPO-PCR-based TR for <i>H. pylori</i> eradication may be equally efficacious, with less treatment-related complications, compared to EBQT in Korea, where clarithromycin resistance is high.